Company profile

OncoSoft. Co., Ltd.

OncoSoft. Co., Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on February 24, 2025 and the most recent on February 24, 2025 (OncoStudio (OS-01)). Its most common review panel is Radiology (1 device).

1AI devices

2025First decision

2025Latest decision

1Specialties

Timeline

February 24, 2025 · 510(k) K242994OncoStudio (OS-01) · Radiology · QKB